Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer

Journal:

Nature Communications

Published:

2025-11-21

DOI:

10.1038/s41467-025-64839-4

Affiliations:

11

Authors:

24

Go to article

Institutions	Authors	Share
Centre Georges-François Leclerc (CGFL), France	6.250000	0.26
Lipids, Nutrition, Cancer (LNC), France	6.166667	0.26
University of Burgundy Europe, France	5.500000	0.23
BioSand – Biologie Santé Dijon, France	3.666667	0.15
University Hospital Basel (USB), UB, Switzerland	1.000000	0.04
Hospital of the University of Montreal (CHUM), Canada	1.000000	0.04
Dijon University Hospital, France	0.250000	0.01
Genomic and Immunotherapy Medical Institute (GIMI), France	0.166667	0.01

Interested in Oncology and Carcinogenesis?